Finance

Lists
300294:SHE
China Resrcs Boya Bio phrmctcl Grp CoLtd
CNÂ¥14.76
-2.45%
(-0.37) 1D
Sep 9, 3:04:55 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300294...
Open
CNÂ¥15.01
High
CNÂ¥15.10
Low
CNÂ¥14.74
Mkt. cap
7.34B
Avg. vol.
6.78M
Volume
5.03M
Dividend
1.51%
Quarterly dividend
CNÂ¥0.06
Ex-dividend date
May 20, 2026
52-wk high
CNÂ¥26.34
52-wk low
CNÂ¥13.64
EPS
-CNÂ¥0.12
Shares outstanding
504.25M
No. of employees
2K
Open
CNÂ¥15.01
High
CNÂ¥15.10
Low
CNÂ¥14.74
Mkt. cap
7.34B
Avg. vol.
6.78M
Volume
5.03M
Dividend
1.51%
Quarterly dividend
CNÂ¥0.06
Ex-dividend date
May 20, 2026
52-wk high
CNÂ¥26.34
52-wk low
CNÂ¥13.64
EPS
-CNÂ¥0.12
Shares outstanding
504.25M
No. of employees
2K
About China Resrcs Boya Bio phrmctcl Grp CoLtd
CEO-
Employees1.95K
FoundedNov 6, 1993
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
466.15M
585.16M
321.13M
322.43M
Cost of goods sold
201.14M
368.48M
172.56M
187.13M
Cost of revenue
201.14M
368.48M
172.56M
187.13M
Research and development expenses
13.68M
17.70M
4.24M
7.75M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
205.24M
134.24M
124.42M
126.58M
Operating expense
224.79M
166.48M
134.93M
139.26M
Total operating expenses
425.93M
534.95M
307.50M
326.39M
Operating income
40.23M
50.21M
13.63M
-3.96M
Other non operating income
2.49M
-5.16M
6.63M
-9.53M
EBT including unusual items
77.85M
-237.46M
36.00M
-32.58M
EBT excluding unusual items
65.33M
53.24M
27.63M
-2.88M
Income tax expense
-39.78M
-7.05M
5.97M
-53.43M
Effective tax rate
-51.11%
2.97%
16.58%
164.01%
Other operating expenses
4.15M
4.44M
4.70M
4.56M
Net income
117.62M
-230.26M
30.22M
20.97M
Net profit margin
25.23%
-39.35%
9.41%
6.50%
Earnings per share
0.09
-0.44
-
-
Interest and investment income
25.58M
2.07M
8.01M
333.67K
Interest expense
-208.09K
-499.08K
-631.04K
-616.37K
Net interest expenses
25.38M
1.58M
7.38M
-282.69K
Depreciation and amortization charges
-
-
-
-
EBITDA
64.65M
85.93M
49.35M
25.10M
Gain or loss from assets sale
5.28M
-5.10M
-
394.88K
AI content may include mistakes. Learn more
Google apps